Target intelligence / Profile preview

TBCC domain containing 1 pseudogene

Molecular classification
Pseudogene, Processed pseudogene (typical for most pseudogenes, but exact type should be verified if needed), Other (not known to encode functional protein)
01

Overview

TBCC domain containing 1 pseudogene (ENSG00000259099) is classified as a pseudogene, specifically lacking known protein-coding potential or established biological function as a receptor, enzyme, or other canonical drug target class[3][4]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations or lack of transcription[4][2]. They can sometimes regulate their protein-coding counterparts by mechanisms such as acting as competitive endogenous RNAs (ceRNAs) or miRNA sponges, affecting gene expression indirectly[1][6], but there is currently no evidence that TBCC domain containing 1 pseudogene plays such a role. Its parent gene, TBCC domain containing 1 (TBCCD1), encodes a centrosomal protein involved in centrosome positioning and internal cell organization, but this function is not attributed to this pseudogene[5]. TBCC domain containing 1 pseudogene is not considered a therapeutic target due to its lack of protein-coding capacity and no known direct biological or disease function[3][4][1].

Other names
LOC100128676
02

Biological functions

Other (no known functional protein product for this pseudogene)Possible regulator of gene expression at RNA level, as seen for other pseudogenes
03

Disease associations

Other (no direct disease association established; most pseudogenes do not have well-defined disease roles unless acting as regulators in RNA networks)

Beyond the preview

Go deeper on TBCC domain containing 1 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TBCC domain containing 1 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call